Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts
Ontology highlight
ABSTRACT: The Banff 2019 kidney allograft pathology update excluded isolated tubulitis without interstitial inflammation (ISO-T) from the category of borderline (suspicious) for acute T cell-mediated rejection due to its proposed benign clinical outcome. In this study, we explored the molecular assessment of ISO-T. ISO-T or interstitial inflammation with tubulitis (I?+?T) was diagnosed in indication biopsies within the first 14 postoperative days. The molecular phenotype of ISO-T was compared to I?+?T either by using RNA sequencing (n?=?16) or by Molecular Microscope Diagnostic System (MMDx, n?=?51). RNA sequencing showed lower expression of genes related to interferon-y (p?=?1.5 *10–16), cytokine signaling (p?=?2.1 *10–20) and inflammatory response (p?=?1.0*10–13) in the ISO-T group than in I?+?T group. Transcripts with increased expression in the I?+?T group overlapped significantly with previously described pathogenesis-based transcript sets associated with cytotoxic and effector T cell transcripts, and with T cell-mediated rejection (TCMR). MMDx classified 25/32 (78%) ISO-T biopsies and 12/19 (63%) I?+?T biopsies as no-rejection. ISO-T had significantly lower MMDx scores for interstitial inflammation (p?=?0.014), tubulitis (p?=?0.035) and TCMR (p?=?0.016) compared to I?+?T. Fewer molecular signals of inflammation in isolated tubulitis suggest that this is also a benign phenotype on a molecular level.
SUBMITTER: Hruba P
PROVIDER: S-EPMC7746707 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA